Richard Pulik - 01 Mar 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role: CFO
Signature: By: /s/ Jo Chen, as Attorney-in-Fact for Richard Pulik
Issuer symbol: ROIV
Transactions as of: 01 Mar 2023
Transactions value $: -$15,449
Form type: 4
Filing time: 03 Mar 2023, 20:00:30 UTC
Previous filing: 22 Apr 2022
Next filing: 31 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ROIV	Common Shares	Sale	-$15,448	-1,912	-0.85%	$8.08	223,347	01 Mar 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.
F2	Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.

Content

Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") previously granted to the reporting person. This sale was effected pursuant to a "sell to cover" policy entered into pursuant to the requirements of Rule 10b5-1 and does not represent a discretionary sale by the reporting person.

Includes Common Shares purchased under the Company's Employee Stock Purchase Plan.